<DOC>
	<DOCNO>NCT01603459</DOCNO>
	<brief_summary>The purpose study determine whether injection increase dos ( 800 unit ) Botulinum toxin type A muscle leg and/or arm safe effective treating patient spasticity one body side due cerebral cause .</brief_summary>
	<brief_title>Efficacy Safety Dose Titration Study Botulinum Toxin Type A Treat Spasticity Leg Arm</brief_title>
	<detailed_description>A dose-titration approach use three injection cycle , flexible observation period injection 12-16 week total duration 48 week . Cycle 1 2 : upper and/or lower limb treat ; Cycle 3 : upper low limb treat .</detailed_description>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Upper low limb spasticity body side due cerebral cause Time since event lead spasticity target body side great 12 week Need 800 unit Botulinum toxin type A Body weight 50kg Fixed contracture target joint Generalized disorder muscle activity like Myasthenia gravis preclude use Botulinum toxin type A Infection injection site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>